Thompson Davis & Co., Inc. Amicus Therapeutics, Inc. Transaction History

Thompson Davis & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $24,000 - $30,403	-2,444 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $4,442 - $6,334	-383 Reduced 13.55%	2,444 $30,000
Q4 2017 Feb 05, 2018	BUY	$12.51 - $16.24 $30,674 - $39,820	2,452 Added 653.87%	2,827 $41,000
Q3 2017 Oct 30, 2017	BUY	$11.74 - $15.78 $4,402 - $5,917	375	375 $6,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.